The Human Chorionic Gonadotropin Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of human chorionic gonadotropin has seen significant growth recently. The market is projected to increase from a value of $0.95 billion in 2024 to $1.03 billion in 2025, with a compound annual growth rate of 8.7%.
The human chorionic gonadotropin market is projected to reach $1.42 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.4%.
Download Your Free Sample of the 2025 Human Chorionic Gonadotropin Market Report and Uncover Key Trends Now!The drivers in the human chorionic gonadotropin market are:
• Rise in the prevalence of hypogonadism in the geriatric population
• Increase in awareness towards Human Chorionic Gonadotropin (HCG) among healthcare professionals and patients
• Growing popularity of fertility tourism
• Improvement and affordability in healthcare facilities
The human chorionic gonadotropin market covered in this report is segmented –
1) By Technology: Natural Source Extraction, Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Fertility Clinics, Research Institutions, Other End Users
The trends in the human chorionic gonadotropin market are:
• There is a rising trend in advancements in pregnancy detection technology.
• A significant trend is the focus on developing innovative drug formulations.
• The market is increasingly influenced by the integration of technology.
• Increasing focus on research and development and product innovation is shaping the future of the market.
The major players in the human chorionic gonadotropin market are:
• Pfizer Inc.
North America was the largest region in the human chorionic gonadotropin market in 2023